MedPath
HSA Approval

SICCAFLUID EYE GEL 0.25%

SIN13063P

SICCAFLUID EYE GEL 0.25%

SICCAFLUID EYE GEL 0.25%

March 10, 2005

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

GEL

**HOW TO USE THIS MEDICINAL PRODUCT** **Dosage** On average, 1 drop 1 to 4 times a day. **Mode and route of administration** Local application OCULAR INSTILLATION. - Wash your hands thoroughly before handling the product. - To allow the formation of a drop of gel, the vial should be shaken before each utilization, and then squeezed gently. - Pulling the lower eyelid down and looking up, place a drop in the inner corner of the eye. - Do not touch the eye with the bottle tip. - Close the bottle after use. - After instillation, the bottle should be kept vertically with the cap downwards, to facilitate the formation of drops when next used. **Frequency and times of administration of the medicinal product** Space out the instillations throughout the day according to need. **Duration of treatment** If symptoms persist or worsen, consult an ophthalmologist, who will adjust your treatment.

OPHTHALMIC

Medical Information

**CASES IN WHICH THIS MEDICINAL PRODUCT SHOULD BE USED (THERAPEUTIC INDICATIONS)** This medicinal product is indicated for the symptomatic treatment of dry eye syndrome.

**WARNING ! CASES IN WHICH THIS MEDICINAL PRODUCT SHOULD NOT BE USED (CONTRAINDICATIONS)** Allergy to any of its components _IN DOUBT SEEK ADVICE FROM YOUR DOCTOR OR PHARMACIST._

S01XA20

artificial tears and other indifferent preparations

Manufacturer Information

DCH AURIGA SINGAPORE

URSAPHARM ARZNEIMITTEL GMBH & CO KG

Active Ingredients

CARBOMER [CARBOMER 974 P (CARBOPOL 974P)]

0.25 G

Carbomer

Documents

Package Inserts

Siccafluid.pdf

Approved: March 9, 2005

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SICCAFLUID EYE GEL 0.25% - HSA Approval | MedPath